U.S. FDA Accepts Filing of HUTCHMED’s NDA for Surufatinib for the Treatment of Advanced Neuroendocrine Tumors

NEXT STORY
Global Power Air Purifying Respirators Market Report 2021: Market to Reach US$3.2 Billion by the Year 2027 – Helmets, Hoods & Visors Segment Corners a 18% Share
PREV STORY
Global Healthcare-Acquired Infection: Devices, Pharmaceuticals, and Environmental Products Market Report to 2026 – Featuring Gilead Sciences, Merck and Novartis Among Others
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Global Precision Medicine Market: Focus on Ecosystem, Technology, Application, Country Data (21 Countries), and Competitive Landscape – Analysis and Forecast, 2020-2030

author_avatar
NASDAQ Market News

Top Biologics Market, 2021-2030

author_avatar
NASDAQ Market News

Checkpoint Therapeutics Announces Issuance of U.S. Composition of Matter Patent for Lung Cancer Compound CK-101

NEW YORK, Feb. 28, 2017 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (OTCQX:CKPT), a ...

author_avatar
NASDAQ Market News